A critical advance in cancer study is emerging with the use of mini-antibodies to reactivate mutated p53. This crucial malignant protector protein is frequently lost in many forms of malignancies, resulting https://bookmarkpressure.com/story21855244/nanobodies-revive-tumor-suppressor-p53-the-potential-hope-for-tumor-therapy